Finally, we determined that C1QA and C1QB expression is enriched in pancreatic cancer patient blood compared with healthy individuals, suggesting that the elevation of these markers may serve as a novel predictor of disease in PDA patients. The gene discussed is C1QA; the disease is familial pancreatic carcinoma.